CAS 164658-13-3
:3-[(4-{2-[(3-chlorophenyl)amino]pyrimidin-4-yl}pyridin-2-yl)amino]propan-1-ol
- 3-(4-(2-(3-Chlorophenylamino)Pyrimidin-4-Yl)Pyridin-2-Ylamino)Propanol
1-Propanol, 3-[[4-[2-[(3-chlorophenyl)amino]-4-pyrimidinyl]-2-pyridinyl]amino]-
CAS:Formula:C18H18ClN5OPurity:99%Color and Shape:SolidMolecular weight:355.82143-((4-(2-((3-Chlorophenyl)Amino)Pyrimidin-4-Yl)Pyridin-2-Yl)Amino)Propan-1-Ol
CAS:3-((4-(2-((3-Chlorophenyl)Amino)Pyrimidin-4-Yl)Pyridin-2-Yl)Amino)Propan-1-OlPurity:98%Molecular weight:355.82g/molCGP 60474
CAS:Controlled ProductApplications CGP 60474 is type of protein kinase C inhibitor (ckd1/cdk2) used in the treatment of different cancers
References Stanetty, P. et al.: J. Org. Chem., 70, 5215 (2005);Formula:C18H18ClN5OColor and Shape:NeatMolecular weight:355.821CGP60474
CAS:CGP60474 is an inhibitor of VEGFR-2 (IC50 = 84 nM) and an inhibitor of ATP-competitive PKC.Formula:C18H18ClN5OPurity:98.81%Color and Shape:SolidMolecular weight:355.82Ref: TM-T14943
1mg34.00€2mg46.00€5mg71.00€10mg92.00€25mg177.00€50mg314.00€100mg518.00€1mL*10mM (DMSO)78.00€CGP 60474
CAS:CGP 60474 is a neurotrophic factor that has been shown to be beneficial for the treatment of inflammatory bowel disease. It binds to intracellular targets, such as kinases, and prevents them from being activated by other molecules. CGP 60474 has also been used in diagnosis of autoimmune diseases and HIV infection. CGP 60474 is a combination preparation with an inhibitor of viral replication that is active against HIV-1, HIV-2, and SIV. The drug inhibits viral replication by binding to the viral envelope protein gp120 and preventing it from binding to the host CD4 receptor on T cells. This prevents viral entry into the cell and subsequent integration into the host genome.
Formula:C18H18ClN5OPurity:Min. 95%Molecular weight:355.82 g/molRef: 3D-PGA65813
Discontinued product





